X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (58176) 58176
Newsletter (9225) 9225
Newspaper Article (2859) 2859
Book Chapter (159) 159
Magazine Article (53) 53
Book / eBook (47) 47
Transcript (19) 19
Dissertation (12) 12
Book Review (9) 9
Conference Proceeding (9) 9
Web Resource (8) 8
Reference (6) 6
Trade Publication Article (6) 6
Report (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Publication (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44700) 44700
male (26162) 26162
female (25584) 25584
hepatitis (21574) 21574
adult (20753) 20753
middle aged (20718) 20718
hepatitis c virus (18059) 18059
hepatitis c (15752) 15752
gastroenterology & hepatology (14482) 14482
health aspects (13654) 13654
virology (13203) 13203
hepatitis b (12085) 12085
infection (11971) 11971
aged (10584) 10584
interferon (10233) 10233
infectious diseases (10148) 10148
research (10056) 10056
liver (9680) 9680
antiviral agents - therapeutic use (9285) 9285
hepatitis b virus (9153) 9153
infections (9068) 9068
viruses (8594) 8594
genotype (8045) 8045
hepacivirus - genetics (7811) 7811
risk factors (7430) 7430
analysis (7147) 7147
virus diseases (7132) 7132
medical research (7035) 7035
liver diseases (7002) 7002
immunology (6936) 6936
animals (6481) 6481
hepatitis c, chronic - drug therapy (6393) 6393
treatment outcome (6171) 6171
prevalence (6010) 6010
care and treatment (5842) 5842
medicine, experimental (5836) 5836
adolescent (5524) 5524
hepatitis c, chronic - virology (5452) 5452
antiviral agents (5343) 5343
hepatitis b virus - genetics (5280) 5280
cirrhosis (5252) 5252
therapy (4977) 4977
genetic aspects (4930) 4930
young adult (4872) 4872
medicine (4871) 4871
research article (4708) 4708
hepatocellular-carcinoma (4648) 4648
liver cancer (4596) 4596
liver cirrhosis (4513) 4513
hepatocellular carcinoma (4431) 4431
patients (4409) 4409
epidemiology (4386) 4386
viral load (4274) 4274
ribavirin (4240) 4240
hiv (4229) 4229
digestive system diseases (4187) 4187
virus-infection (4150) 4150
microbiology (4102) 4102
hepatitis c - virology (4088) 4088
biological response modifiers (4053) 4053
interferon-alpha - therapeutic use (4024) 4024
multidisciplinary sciences (3949) 3949
rna (3929) 3929
retrospective studies (3918) 3918
disease (3907) 3907
hcv (3897) 3897
proteins (3877) 3877
hepatitis c, chronic - complications (3876) 3876
drug therapy, combination (3792) 3792
hepatology (3673) 3673
fibrosis (3566) 3566
drug therapy (3418) 3418
antigens (3391) 3391
hepatitis b, chronic - virology (3386) 3386
polymerase chain reaction (3385) 3385
communicable diseases (3382) 3382
science (3347) 3347
liver - pathology (3342) 3342
cancer (3300) 3300
expression (3250) 3250
oncology (3240) 3240
ribavirin - therapeutic use (3228) 3228
liver cirrhosis - virology (3219) 3219
genotypes (3215) 3215
mutation (3200) 3200
hepacivirus - isolation & purification (3147) 3147
replication (3137) 3137
rna, viral - blood (3112) 3112
liver neoplasms - virology (3111) 3111
carcinoma, hepatocellular - virology (3090) 3090
human immunodeficiency virus--hiv (3036) 3036
risk (3030) 3030
mortality (3017) 3017
mice (3015) 3015
hepatitis c - complications (2999) 2999
transplantation (2983) 2983
dna (2980) 2980
diagnosis (2940) 2940
pharmacology & pharmacy (2919) 2919
studies (2843) 2843
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (69667) 69667
Chinese (373) 373
French (244) 244
Portuguese (241) 241
Japanese (202) 202
Spanish (172) 172
Russian (137) 137
German (122) 122
Polish (62) 62
Hungarian (43) 43
Turkish (37) 37
Korean (36) 36
Italian (26) 26
Czech (24) 24
Croatian (21) 21
Norwegian (13) 13
Danish (9) 9
Serbian (9) 9
Hebrew (5) 5
Romanian (5) 5
Arabic (4) 4
Swedish (4) 4
Dutch (3) 3
Slovak (3) 3
Ukrainian (3) 3
Icelandic (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of clinical investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide Current treatment for chronic infection is a combination of pegylated. IFN-alpha(2) and ribavirin (RBV... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2016, Volume 150, Issue 7, pp. 1599 - 1608
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2015, Volume 149, Issue 6, pp. 1345 - 1360
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations... 
Gastroenterology and Hepatology | Fatigue | Cryoglobulins | Cardiovascular Risk | Health-Related Quality of Life | Insulin Resistance | PORPHYRIA-CUTANEA-TARDA | MIXED CRYOGLOBULINEMIA VASCULITIS | PATIENT-REPORTED OUTCOMES | SUSTAINED VIROLOGICAL RESPONSE | MAGNETIC-RESONANCE-SPECTROSCOPY | POPULATION-BASED COHORT | ALPHA-2A PLUS RIBAVIRIN | QUALITY-OF-LIFE | CHRONIC HCV INFECTION | IDIOPATHIC PULMONARY-FIBROSIS | GASTROENTEROLOGY & HEPATOLOGY | Interferon-alpha - pharmacology | Vasculitis - epidemiology | Humans | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Vasculitis - virology | Cryoglobulinemia - virology | Hepatitis C, Chronic - mortality | Cryoglobulinemia - epidemiology | Glucose Metabolism Disorders - virology | Hepatitis C, Chronic - epidemiology | Glomerulonephritis - epidemiology | Hepacivirus - drug effects | Lymphoma - epidemiology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Glomerulonephritis - virology | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Morbidity | Hepatitis C, Chronic - immunology | Glucose Metabolism Disorders - epidemiology | Ribavirin - pharmacology | Lymphoma - virology | Medical colleges | Patient outcomes | Liver | Mortality | Atherosclerosis | Insulin resistance | Lymphomas | Hepatitis C | Biological response modifiers | Hepatitis C virus
Journal Article
Journal of hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 1, pp. S58 - S68
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2011, Volume 141, Issue 4, pp. 1220 - 1230.e3
Background & Aims Chronic infection with hepatitis B or C virus (HBV or HCV) is a leading cause of cirrhosis by unknown mechanisms of pathogenesis... 
Gastroenterology and Hepatology | Hepatitis | Soluble CD14 | Intestinal Fatty Acid Binding Protein | Microbial Translocation | CELLS | ENDOTOXIN | LIVER-DISEASE | BACTEROIDES-FRAGILIS | ACID-BINDING-PROTEIN | C VIRUS-INFECTION | LIPOPOLYSACCHARIDE | GASTROENTEROLOGY & HEPATOLOGY | HEPATITIS-C | EXPRESSION | Liver Cirrhosis - immunology | Hepatitis B, Chronic - immunology | Humans | Middle Aged | Male | Monocytes - immunology | End Stage Liver Disease - microbiology | Intestines - immunology | Fatty Acid-Binding Proteins - blood | Enterocytes - pathology | Odds Ratio | Monocytes - microbiology | Hypertension, Portal - microbiology | Logistic Models | Biomarkers - blood | Hepatitis C, Chronic - diagnosis | Disease Progression | Lipopolysaccharide Receptors - blood | Host-Pathogen Interactions | Monocytes - virology | Intestines - microbiology | Hepatitis C, Chronic - microbiology | Maryland | Enterocytes - virology | Hepatitis B, Chronic - diagnosis | Hepatitis C, Chronic - complications | Kupffer Cells - virology | Lipopolysaccharides - blood | Interleukin-6 - blood | Cell Death | Intestines - virology | Female | Retrospective Studies | Hypertension, Portal - virology | Severity of Illness Index | Liver Cirrhosis - diagnosis | Intestines - pathology | Enzyme-Linked Immunosorbent Assay | Hepatitis B, Chronic - microbiology | Kupffer Cells - microbiology | Bacterial Translocation | Enterocytes - microbiology | Hepatitis B, Chronic - complications | Liver Cirrhosis - virology | Biopsy | Hepatitis C, Chronic - immunology | Liver Cirrhosis - microbiology | Limulus Test | End Stage Liver Disease - virology | Medical research | Phosphatases | Patient outcomes | Aspartate | Permeability | HIV (Viruses) | Transforming growth factors | Fatty acids | Medicine, Experimental | Kidney diseases | Hepatitis C virus | Mitogens | Hepatitis B | Protein binding | microbiota | histology | immune response | soluble CD14 | intestinal fatty acid binding protein | chronic liver disease | Microbial translocation | hepatitis
Journal Article
PloS one, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133236
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy... 
VIRUS-INFECTION | CHEMOKINES | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PROTEIN-10 | GENOTYPE 1 INFECTION | PREDICTIVE-VALUE | RIBAVIRIN | INDUCTION | ASSOCIATION | SPONTANEOUS CLEARANCE | Recurrence | Interferons | Humans | Fluorenes - therapeutic use | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Male | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Virus Replication - drug effects | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Convalescence | Chemokine CXCL10 - genetics | Protein Processing, Post-Translational | Hepatitis C, Chronic - genetics | Viral Load - drug effects | Infection | Care and treatment | Analysis | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Therapy | Laboratories | Chronic infection | Critical care | Amino acids | Infections | Ribavirin | Clinical outcomes | Proteins | Genotype & phenotype | Hepatitis | Immunology | Hepatology | Post-translation | Pretreatment | Drug dosages | Genotypes | Statistical analysis | Liver diseases | Dendritic cells | Serum levels | Studies | Infectious diseases | CXCL10 protein | Biomarkers | Chemokines | Virus Replication/drug effects | Viral Load/drug effects | Dipeptidyl Peptidase 4/blood | Dipeptidyl Peptidase 4/genetics | Chemokine CXCL10/blood | Hepatitis C, Chronic/blood | Life Sciences | Hepatitis C, Chronic/drug therapy | Hepatitis C, Chronic/virology | Hepatitis C, Chronic/genetics | Chemokine CXCL10/genetics | Benzimidazoles/therapeutic use | Hepacivirus/physiology | Fluorenes/therapeutic use | Antiviral Agents/therapeutic use | Sofosbuvir/therapeutic use | Hepacivirus/drug effects | Ribavirin/therapeutic use
Journal Article
PloS one, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0174453
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article